[Diabetic retinopathy].

By T. Sano, N. Hotta. Nihon rinsho. Japanese journal of clinical medicine, 2001

6,191 citations recorded by the source corpus.

Subfields: Ophthalmology, Radiology, Nuclear Medicine and Imaging

View Paper: https://www.semanticscholar.org/paper/d7500b394ec0b048a4362f5757eff9c6690a7bcd

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Ophthalmology

In Radiology, Nuclear Medicine and Imaging

Citations in the corpus

Endoplasmic reticulum stress: molecular mechanism and therapeutic targets (2023, background): “220 In a survey conducted in a Han Chinese population, insulin-like growth factor 1 gene polymorphisms (rs6218, rs35767, and rs35767) were associated with DR. 221 Insulin-like growth factor 1 facilitates the MG to induce neovascularization, whose expression can be upregulated under ER stress.”
Diabetic Retinopathy: A Position Statement by the American Diabetes Association (2017, background): “However, in eyes with CIDME and lower levels of acuity, 20/50 or worse, aflibercept appears to be most effective at improving visual acuity (38).”
Algorithms for the Automated Detection of Diabetic Retinopathy Using Digital Fundus Images: A Review (2012, background): “To ensure that DR treatment is received on time, the eye fundus images of diabetic patients must be examined at least once a year [22].”
Standards of Medical Care in Diabetes—2009 (2009, background): “Several case series and a controlled prospective study suggest that pregnancy in type 1 diabetic pat ients may aggravate ret inopathy (258,259); laser photocoagulation surgery can minimize this risk (259).”
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema: Two-year Results from a Comparative Effectiveness Randomized Clinical Trial (2016, neutral): “(%) 2 (2) 4 (4) 2 (2) 2 ( 7 to þ3) P 1⁄4 0.”
Oxidative Stress and Diabetic Retinopathy (2007, background): “Due to progressive dysfunction, the capillaries die prematurely leading to ischemia that can be followed by neovascularization, and ultimately retinal detachment and blindness [6, 7].”
Retinal Fundus Multi-Disease Image Dataset (RFMiD): A Dataset for Multi-Disease Detection Research (2021, background): “The image is labeled as DR if it shows any of the following clinical findings: microaneurysms, retinal dot and blot hemorrhage, hard exudates or cotton wool spots (see Figure 2a) [17].”
Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. (2011, background): “Pericytes in Diabetic Retinopathy Diabetic retinopathy is one of the most common complications of diabetes, with one-third of adult diabetic patients affected, and constitutes a leading cause of blindness (Cheung et al., 2010).”
Pivotal trial of an autonomous AI-based diagnostic system for detection of diabetic retinopathy in primary care offices (2018, background): “Diabetic retinopathy (DR) is the primary cause of blindness and visual loss among working age men and women in the United States and causes more than 24,000 people to lose vision each year.(2,3) Adherence to regular eye examinations is necessary to diagnose DR at an early stage, when it can be treat”
Retinal neurodegeneration may precede microvascular changes characteristic of diabetic retinopathy in diabetes mellitus (2016, background): “Invest Ophthalmol Vis Sci 56(1):259–271.”
Standards of Medical Care in Diabetes–2006 (2006, background): “Several case series and a controlled prospective study suggest that pregnancy in type 1 diabetic patients may aggravate retinopathy (168).”
Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE. (2013, background): “A more important potential limitation is that ranibizumab was administered on a continuous monthly dosing schedule, which may optimize efficacy but not be practical for many patients with DME.”
Automated diabetic retinopathy detection in smartphone-based fundus photography using artificial intelligence (2018, background): “All individuals with diabetes, irrespective of the type of diabetes, require regular and repetitive annual retinal screening for early detection and timely treatment of diabetic retinopathy (DR), particularly sight-threatening diabetic retinopathy (STDR) [1, 2].”